MiMedx Group Inc. (NASDAQ:MDXG) is a regenerative biomaterials company with a patented allograft tissue technology that has application potential in a wide array of healthcare fields. Led by CEO Parker Petit, a legend in the healthcare space who previously sold two companies for billions, and a number of high-level executives from his previous ventures, MiMedx has assembled a management team with the experience and savvy to create another billion dollar market-cap company.
With a $10 billion opportunity in front of it, which could potentially grow into a $15-20 billion opportunity, MiMedx is on a runway which could create exponential growth over the next few years. Although shares of MDXG have already enjoyed nice gains since the...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|